[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Sleep Disorder Therapies Market Size, Status and Forecast 2020-2026

July 2020 | 95 pages | ID: C3966B95D847EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sleep Disorder Therapies market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Sleep Disorder Therapies industry.

Based on our recent survey, we have several different scenarios about the Sleep Disorder Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Sleep Disorder Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sleep Disorder Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sleep Disorder Therapies market in terms of revenue.

Players, stakeholders, and other participants in the global Sleep Disorder Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Sleep Disorder Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Sleep Disorder Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sleep Disorder Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sleep Disorder Therapies market.

The following players are covered in this report:
  • Sanofi
  • Phillips Healthcare
  • Nox Medical
  • Fisher and Paykel Healthcare
  • Responsive Surface Technology
  • Eight Sleep
  • Sleep Number
  • Vanda Pharmaceuticals
  • Eli Lilly
  • Neurim Pharmaceuticals
  • Merck
Sleep Disorder Therapies Breakdown Data by Type
  • Insomnia
  • Excessive Sleep
  • Disturbed Sleep
Sleep Disorder Therapies Breakdown Data by Application
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sleep Disorder Therapies Revenue
1.4 Market Analysis by Type
  1.4.1 Global Sleep Disorder Therapies Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Insomnia
  1.4.3 Excessive Sleep
  1.4.4 Disturbed Sleep
1.5 Market by Application
  1.5.1 Global Sleep Disorder Therapies Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Online Pharmacies
  1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Sleep Disorder Therapies Industry Impact
  1.6.1 How the Covid-19 is Affecting the Sleep Disorder Therapies Industry
    1.6.1.1 Sleep Disorder Therapies Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Sleep Disorder Therapies Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Sleep Disorder Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Sleep Disorder Therapies Market Perspective (2015-2026)
2.2 Sleep Disorder Therapies Growth Trends by Regions
  2.2.1 Sleep Disorder Therapies Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Sleep Disorder Therapies Historic Market Share by Regions (2015-2020)
  2.2.3 Sleep Disorder Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Sleep Disorder Therapies Market Growth Strategy
  2.3.6 Primary Interviews with Key Sleep Disorder Therapies Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Sleep Disorder Therapies Players by Market Size
  3.1.1 Global Top Sleep Disorder Therapies Players by Revenue (2015-2020)
  3.1.2 Global Sleep Disorder Therapies Revenue Market Share by Players (2015-2020)
  3.1.3 Global Sleep Disorder Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sleep Disorder Therapies Market Concentration Ratio
  3.2.1 Global Sleep Disorder Therapies Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapies Revenue in 2019
3.3 Sleep Disorder Therapies Key Players Head office and Area Served
3.4 Key Players Sleep Disorder Therapies Product Solution and Service
3.5 Date of Enter into Sleep Disorder Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Sleep Disorder Therapies Historic Market Size by Type (2015-2020)
4.2 Global Sleep Disorder Therapies Forecasted Market Size by Type (2021-2026)

5 SLEEP DISORDER THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Sleep Disorder Therapies Market Size by Application (2015-2020)
5.2 Global Sleep Disorder Therapies Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Sleep Disorder Therapies Market Size (2015-2020)
6.2 Sleep Disorder Therapies Key Players in North America (2019-2020)
6.3 North America Sleep Disorder Therapies Market Size by Type (2015-2020)
6.4 North America Sleep Disorder Therapies Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Sleep Disorder Therapies Market Size (2015-2020)
7.2 Sleep Disorder Therapies Key Players in Europe (2019-2020)
7.3 Europe Sleep Disorder Therapies Market Size by Type (2015-2020)
7.4 Europe Sleep Disorder Therapies Market Size by Application (2015-2020)

8 CHINA

8.1 China Sleep Disorder Therapies Market Size (2015-2020)
8.2 Sleep Disorder Therapies Key Players in China (2019-2020)
8.3 China Sleep Disorder Therapies Market Size by Type (2015-2020)
8.4 China Sleep Disorder Therapies Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Sleep Disorder Therapies Market Size (2015-2020)
9.2 Sleep Disorder Therapies Key Players in Japan (2019-2020)
9.3 Japan Sleep Disorder Therapies Market Size by Type (2015-2020)
9.4 Japan Sleep Disorder Therapies Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Sleep Disorder Therapies Market Size (2015-2020)
10.2 Sleep Disorder Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sleep Disorder Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Sleep Disorder Therapies Market Size by Application (2015-2020)

11 INDIA

11.1 India Sleep Disorder Therapies Market Size (2015-2020)
11.2 Sleep Disorder Therapies Key Players in India (2019-2020)
11.3 India Sleep Disorder Therapies Market Size by Type (2015-2020)
11.4 India Sleep Disorder Therapies Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Sleep Disorder Therapies Market Size (2015-2020)
12.2 Sleep Disorder Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Sleep Disorder Therapies Market Size by Type (2015-2020)
12.4 Central & South America Sleep Disorder Therapies Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Sanofi
  13.1.1 Sanofi Company Details
  13.1.2 Sanofi Business Overview and Its Total Revenue
  13.1.3 Sanofi Sleep Disorder Therapies Introduction
  13.1.4 Sanofi Revenue in Sleep Disorder Therapies Business (2015-2020))
  13.1.5 Sanofi Recent Development
13.2 Phillips Healthcare
  13.2.1 Phillips Healthcare Company Details
  13.2.2 Phillips Healthcare Business Overview and Its Total Revenue
  13.2.3 Phillips Healthcare Sleep Disorder Therapies Introduction
  13.2.4 Phillips Healthcare Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.2.5 Phillips Healthcare Recent Development
13.3 Nox Medical
  13.3.1 Nox Medical Company Details
  13.3.2 Nox Medical Business Overview and Its Total Revenue
  13.3.3 Nox Medical Sleep Disorder Therapies Introduction
  13.3.4 Nox Medical Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.3.5 Nox Medical Recent Development
13.4 Fisher and Paykel Healthcare
  13.4.1 Fisher and Paykel Healthcare Company Details
  13.4.2 Fisher and Paykel Healthcare Business Overview and Its Total Revenue
  13.4.3 Fisher and Paykel Healthcare Sleep Disorder Therapies Introduction
  13.4.4 Fisher and Paykel Healthcare Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.4.5 Fisher and Paykel Healthcare Recent Development
13.5 Responsive Surface Technology
  13.5.1 Responsive Surface Technology Company Details
  13.5.2 Responsive Surface Technology Business Overview and Its Total Revenue
  13.5.3 Responsive Surface Technology Sleep Disorder Therapies Introduction
  13.5.4 Responsive Surface Technology Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.5.5 Responsive Surface Technology Recent Development
13.6 Eight Sleep
  13.6.1 Eight Sleep Company Details
  13.6.2 Eight Sleep Business Overview and Its Total Revenue
  13.6.3 Eight Sleep Sleep Disorder Therapies Introduction
  13.6.4 Eight Sleep Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.6.5 Eight Sleep Recent Development
13.7 Sleep Number
  13.7.1 Sleep Number Company Details
  13.7.2 Sleep Number Business Overview and Its Total Revenue
  13.7.3 Sleep Number Sleep Disorder Therapies Introduction
  13.7.4 Sleep Number Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.7.5 Sleep Number Recent Development
13.8 Vanda Pharmaceuticals
  13.8.1 Vanda Pharmaceuticals Company Details
  13.8.2 Vanda Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Vanda Pharmaceuticals Sleep Disorder Therapies Introduction
  13.8.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.8.5 Vanda Pharmaceuticals Recent Development
13.9 Eli Lilly
  13.9.1 Eli Lilly Company Details
  13.9.2 Eli Lilly Business Overview and Its Total Revenue
  13.9.3 Eli Lilly Sleep Disorder Therapies Introduction
  13.9.4 Eli Lilly Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.9.5 Eli Lilly Recent Development
13.10 Neurim Pharmaceuticals
  13.10.1 Neurim Pharmaceuticals Company Details
  13.10.2 Neurim Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 Neurim Pharmaceuticals Sleep Disorder Therapies Introduction
  13.10.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2015-2020)
  13.10.5 Neurim Pharmaceuticals Recent Development
13.11 Merck
  10.11.1 Merck Company Details
  10.11.2 Merck Business Overview and Its Total Revenue
  10.11.3 Merck Sleep Disorder Therapies Introduction
  10.11.4 Merck Revenue in Sleep Disorder Therapies Business (2015-2020)
  10.11.5 Merck Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Sleep Disorder Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Sleep Disorder Therapies Revenue
Table 3. Ranking of Global Top Sleep Disorder Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sleep Disorder Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Insomnia
Table 6. Key Players of Excessive Sleep
Table 7. Key Players of Disturbed Sleep
Table 8. COVID-19 Impact Global Market: (Four Sleep Disorder Therapies Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Sleep Disorder Therapies Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Sleep Disorder Therapies Players to Combat Covid-19 Impact
Table 13. Global Sleep Disorder Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Sleep Disorder Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Sleep Disorder Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Sleep Disorder Therapies Market Share by Regions (2015-2020)
Table 17. Global Sleep Disorder Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Sleep Disorder Therapies Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Sleep Disorder Therapies Market Growth Strategy
Table 23. Main Points Interviewed from Key Sleep Disorder Therapies Players
Table 24. Global Sleep Disorder Therapies Revenue by Players (2015-2020) (Million US$)
Table 25. Global Sleep Disorder Therapies Market Share by Players (2015-2020)
Table 26. Global Top Sleep Disorder Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sleep Disorder Therapies as of 2019)
Table 27. Global Sleep Disorder Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Sleep Disorder Therapies Product Solution and Service
Table 30. Date of Enter into Sleep Disorder Therapies Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Sleep Disorder Therapies Market Size by Type (2015-2020) (Million US$)
Table 33. Global Sleep Disorder Therapies Market Size Share by Type (2015-2020)
Table 34. Global Sleep Disorder Therapies Revenue Market Share by Type (2021-2026)
Table 35. Global Sleep Disorder Therapies Market Size Share by Application (2015-2020)
Table 36. Global Sleep Disorder Therapies Market Size by Application (2015-2020) (Million US$)
Table 37. Global Sleep Disorder Therapies Market Size Share by Application (2021-2026)
Table 38. North America Key Players Sleep Disorder Therapies Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Sleep Disorder Therapies Market Share (2019-2020)
Table 40. North America Sleep Disorder Therapies Market Size by Type (2015-2020) (Million US$)
Table 41. North America Sleep Disorder Therapies Market Share by Type (2015-2020)
Table 42. North America Sleep Disorder Therapies Market Size by Application (2015-2020) (Million US$)
Table 43. North America Sleep Disorder Therapies Market Share by Application (2015-2020)
Table 44. Europe Key Players Sleep Disorder Therapies Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Sleep Disorder Therapies Market Share (2019-2020)
Table 46. Europe Sleep Disorder Therapies Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Sleep Disorder Therapies Market Share by Type (2015-2020)
Table 48. Europe Sleep Disorder Therapies Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Sleep Disorder Therapies Market Share by Application (2015-2020)
Table 50. China Key Players Sleep Disorder Therapies Revenue (2019-2020) (Million US$)
Table 51. China Key Players Sleep Disorder Therapies Market Share (2019-2020)
Table 52. China Sleep Disorder Therapies Market Size by Type (2015-2020) (Million US$)
Table 53. China Sleep Disorder Therapies Market Share by Type (2015-2020)
Table 54. China Sleep Disorder Therapies Market Size by Application (2015-2020) (Million US$)
Table 55. China Sleep Disorder Therapies Market Share by Application (2015-2020)
Table 56. Japan Key Players Sleep Disorder Therapies Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Sleep Disorder Therapies Market Share (2019-2020)
Table 58. Japan Sleep Disorder Therapies Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Sleep Disorder Therapies Market Share by Type (2015-2020)
Table 60. Japan Sleep Disorder Therapies Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Sleep Disorder Therapies Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Sleep Disorder Therapies Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Sleep Disorder Therapies Market Share (2019-2020)
Table 64. Southeast Asia Sleep Disorder Therapies Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Sleep Disorder Therapies Market Share by Type (2015-2020)
Table 66. Southeast Asia Sleep Disorder Therapies Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Sleep Disorder Therapies Market Share by Application (2015-2020)
Table 68. India Key Players Sleep Disorder Therapies Revenue (2019-2020) (Million US$)
Table 69. India Key Players Sleep Disorder Therapies Market Share (2019-2020)
Table 70. India Sleep Disorder Therapies Market Size by Type (2015-2020) (Million US$)
Table 71. India Sleep Disorder Therapies Market Share by Type (2015-2020)
Table 72. India Sleep Disorder Therapies Market Size by Application (2015-2020) (Million US$)
Table 73. India Sleep Disorder Therapies Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Sleep Disorder Therapies Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Sleep Disorder Therapies Market Share (2019-2020)
Table 76. Central & South America Sleep Disorder Therapies Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Sleep Disorder Therapies Market Share by Type (2015-2020)
Table 78. Central & South America Sleep Disorder Therapies Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Sleep Disorder Therapies Market Share by Application (2015-2020)
Table 80. Sanofi Company Details
Table 81. Sanofi Business Overview
Table 82. Sanofi Product
Table 83. Sanofi Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 84. Sanofi Recent Development
Table 85. Phillips Healthcare Company Details
Table 86. Phillips Healthcare Business Overview
Table 87. Phillips Healthcare Product
Table 88. Phillips Healthcare Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 89. Phillips Healthcare Recent Development
Table 90. Nox Medical Company Details
Table 91. Nox Medical Business Overview
Table 92. Nox Medical Product
Table 93. Nox Medical Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 94. Nox Medical Recent Development
Table 95. Fisher and Paykel Healthcare Company Details
Table 96. Fisher and Paykel Healthcare Business Overview
Table 97. Fisher and Paykel Healthcare Product
Table 98. Fisher and Paykel Healthcare Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 99. Fisher and Paykel Healthcare Recent Development
Table 100. Responsive Surface Technology Company Details
Table 101. Responsive Surface Technology Business Overview
Table 102. Responsive Surface Technology Product
Table 103. Responsive Surface Technology Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 104. Responsive Surface Technology Recent Development
Table 105. Eight Sleep Company Details
Table 106. Eight Sleep Business Overview
Table 107. Eight Sleep Product
Table 108. Eight Sleep Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 109. Eight Sleep Recent Development
Table 110. Sleep Number Company Details
Table 111. Sleep Number Business Overview
Table 112. Sleep Number Product
Table 113. Sleep Number Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 114. Sleep Number Recent Development
Table 115. Vanda Pharmaceuticals Business Overview
Table 116. Vanda Pharmaceuticals Product
Table 117. Vanda Pharmaceuticals Company Details
Table 118. Vanda Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 119. Vanda Pharmaceuticals Recent Development
Table 120. Eli Lilly Company Details
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Product
Table 123. Eli Lilly Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 124. Eli Lilly Recent Development
Table 125. Neurim Pharmaceuticals Company Details
Table 126. Neurim Pharmaceuticals Business Overview
Table 127. Neurim Pharmaceuticals Product
Table 128. Neurim Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 129. Neurim Pharmaceuticals Recent Development
Table 130. Merck Company Details
Table 131. Merck Business Overview
Table 132. Merck Product
Table 133. Merck Revenue in Sleep Disorder Therapies Business (2015-2020) (Million US$)
Table 134. Merck Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Sleep Disorder Therapies Market Share by Type: 2020 VS 2026
Figure 2. Insomnia Features
Figure 3. Excessive Sleep Features
Figure 4. Disturbed Sleep Features
Figure 5. Global Sleep Disorder Therapies Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Sleep Disorder Therapies Report Years Considered
Figure 10. Global Sleep Disorder Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Sleep Disorder Therapies Market Share by Regions: 2020 VS 2026
Figure 12. Global Sleep Disorder Therapies Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Sleep Disorder Therapies Market Share by Players in 2019
Figure 15. Global Top Sleep Disorder Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sleep Disorder Therapies as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Sleep Disorder Therapies Revenue in 2019
Figure 17. North America Sleep Disorder Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Sleep Disorder Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Sleep Disorder Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Sleep Disorder Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Sleep Disorder Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Sleep Disorder Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Sleep Disorder Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Sanofi Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 26. Phillips Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Phillips Healthcare Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 28. Nox Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Nox Medical Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 30. Fisher and Paykel Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Fisher and Paykel Healthcare Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 32. Responsive Surface Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Responsive Surface Technology Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 34. Eight Sleep Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Eight Sleep Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 36. Sleep Number Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Sleep Number Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 38. Vanda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Vanda Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 40. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Eli Lilly Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 42. Neurim Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Neurim Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 44. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Merck Revenue Growth Rate in Sleep Disorder Therapies Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed


More Publications